A month after partnering its JAK3 inhibitor program in a potential $189 million deal with Madison, N.J.-based Wyeth, Pharmacopeia Drug Discovery Inc., of Princeton, N.J., signed another collaboration with Organon, of Oss, the Netherlands, to discover and develop small-molecule drugs against a range of indications. That …
No comments:
Post a Comment